BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $4,611,000 | -70.4% | 4,500,000 | -70.0% | 0.02% | -70.6% |
Q2 2021 | $15,566,000 | +1.7% | 15,000,000 | 0.0% | 0.07% | +3.0% |
Q1 2021 | $15,299,000 | -4.6% | 15,000,000 | 0.0% | 0.07% | +10.0% |
Q4 2020 | $16,033,000 | +2.4% | 15,000,000 | 0.0% | 0.06% | -4.8% |
Q3 2020 | $15,650,000 | -14.7% | 15,000,000 | 0.0% | 0.06% | -22.2% |
Q2 2020 | $18,340,000 | +17.7% | 15,000,000 | 0.0% | 0.08% | -15.6% |
Q1 2020 | $15,576,000 | -1.7% | 15,000,000 | 0.0% | 0.10% | +14.3% |
Q4 2019 | $15,841,000 | +7.6% | 15,000,000 | 0.0% | 0.08% | -16.0% |
Q3 2019 | $14,722,000 | -5.4% | 15,000,000 | 0.0% | 0.10% | -5.7% |
Q2 2019 | $15,566,000 | +1.2% | 15,000,000 | 0.0% | 0.11% | +8.2% |
Q1 2019 | $15,385,000 | +3.2% | 15,000,000 | 0.0% | 0.10% | -19.7% |
Q4 2018 | $14,911,000 | -5.7% | 15,000,000 | 0.0% | 0.12% | +17.3% |
Q3 2018 | $15,818,000 | +4.1% | 15,000,000 | 0.0% | 0.10% | -8.8% |
Q2 2018 | $15,198,000 | +7.8% | 15,000,000 | 0.0% | 0.11% | -5.0% |
Q1 2018 | $14,099,000 | -5.6% | 15,000,000 | 0.0% | 0.12% | -7.0% |
Q4 2017 | $14,928,000 | -1.7% | 15,000,000 | 0.0% | 0.13% | +4.9% |
Q3 2017 | $15,193,000 | – | 15,000,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |